The endogenous opioid system plays a key role in alcoholism. The different regulations of these genes are not only linked to the amount of alcohol consumed, but also to sex, as demonstrated in a rodent model. Therefore, the influence of sex in elucidating the mechanism of alcoholism should not be overlooked [1].
In alcohol use disorder, the endogenous opioid system genes seem to play a pivotal role [1]. For a better understanding of how alcohol consumption affects genes transcription, it is important to analyse when alcohol consumption occurs, especially in critical developmental periods such as adolescence. Mr Fabio Bellia (University of Teramo, Italy) and colleagues studied the potential effects of alcohol consumption in rats during adolescence on opioid system gene transcription in adulthood.
A short-term selection of rats was performed in an intermittent-access ethanol-intake protocol to generate 2 lines of high- and low-ethanol consumption in the animals. Twelve high ethanol-consumption animals and 12 low ethanol-consumption animals were randomly selected. Their brains were dissected 100 days after birth and 40 days after the last ethanol intake session. Total RNA was extracted and opioid messenger (m)RNA levels were assessed in the prefrontal cortex, nucleus accumbens, and ventral tegmental area with real-time quantitative polymerase chain reaction.
The 2 groups of rats exhibited differences in the expression of endogenous opioid system genes, observed in adulthood in different brain regions. Although there were no major differences in the quantity of alcohol consumed, the alterations in gene expression were more visible in males than in females. The levels of alcohol consumed significantly correlated with gene expression, which suggests that the altered expression of these genes in the brain is directly due to the amount of alcohol consumed during adolescence or is attributable to innate differences between the 2 lines.
- Bellia F, et al. Long-term consequences of alcohol consumption: sex-dependent endogenous opioid system genes regulation. P.001. ECNP Congress 2020.
Posted on
Previous Article
« Subgroups in alcohol use disorder based on externalising symptoms Next Article
Micronutrient supplementation as treatment for psychiatric symptoms »
« Subgroups in alcohol use disorder based on externalising symptoms Next Article
Micronutrient supplementation as treatment for psychiatric symptoms »
Table of Contents: ECNP 2020
Featured articles
Psychosis and Schizophrenia
Prognostic tools in the management of clinical high risk for psychosis
Reduced auditory cortex activation during speech perception in patients with schizophrenia
Dementia
Predicting MCI and dementia by assessing worrying about memory
Genomics of vascular dementia and stroke
Bipolar Disorders
Social media and bipolar disorder: a risky combination
How to prevent the onset and first relapse of bipolar disorders?
Seasonal pattern and bipolar disorder
OCD and Depression
Personalised medicine in depression: a realistic way forward?
Heart rate could be a potential biomarker for depression
Listening to Mozart has a beneficial effect on epilepsy
Mental Health
Mental health during the COVID-19 pandemic
Microdosing psychedelics offers perspective but needs further evaluation
The PRISM project: focusing on biological parameters across neuropsychiatric disorders
Smartphone can support personalised medicine in psychiatry
Baby’s heart rate shows stress if their mother is depressed or anxious
Autism and ADHD
Movement computing promising in analysing motor impairment in children with autism spectrum disorder
Screening with ADHD Self-Report accurate in girls
No altered fractional anisotropy in ADHD
Role of the Microbiome
Micronutrient supplementation as treatment for psychiatric symptoms
Substance Abuse
Altered gene expression of endogenous opioid system after alcohol exposure in adolescent rodents
Subgroups in alcohol use disorder based on externalising symptoms
New drugs for alcohol use disorder to focus on combination therapy
Related Articles
February 9, 2022
Biomarker in platelets may pinpoint depression, treatment response

November 2, 2020
Smartphone can support personalised medicine in psychiatry
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy